BR0108438A - Composição farmacêutica - Google Patents

Composição farmacêutica

Info

Publication number
BR0108438A
BR0108438A BR0108438-0A BR0108438A BR0108438A BR 0108438 A BR0108438 A BR 0108438A BR 0108438 A BR0108438 A BR 0108438A BR 0108438 A BR0108438 A BR 0108438A
Authority
BR
Brazil
Prior art keywords
membrane
solvent
nail
forming
solution
Prior art date
Application number
BR0108438-0A
Other languages
English (en)
Inventor
Robert J Gyurik
Original Assignee
Bentley Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bentley Pharmaceuticals Inc filed Critical Bentley Pharmaceuticals Inc
Publication of BR0108438A publication Critical patent/BR0108438A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA". Uma composição compreendendo um composto farmacêutico, um aperfeiçoador de permeação - membrana, e um agente de formação de filme polimérico, incluindo, por exemplo, uma laca de unha líquida baseada em hidrocarboneto compreendendo uma solução de um agente anti - fungo em uma quantidade farmaceuticamente efetiva, um aperfeiçoador de permeação compatível com membrana em uma quantidade efetiva para aperfeiçoar penetração através de uma membrana ou unha do dito agente anti - fungo , um agente formador de filme polimérico em uma quantidade efetiva para formar um filme polimérico aderente sobre uma membrana ou unha, e um solvente para formação da dita solução; e um processo para formação sobre uma membrana ou unha do corpo de um filme aderente contendo um composto farmacêutico e aperfeiçoador de permeação a partir de uma solução dos componentes onde é usada uma mistura de solventes, incluindo um solvente que é altamente volátil e um solvente de menor volatilidade.
BR0108438-0A 2000-02-16 2001-02-16 Composição farmacêutica BR0108438A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
BR0108438A true BR0108438A (pt) 2003-04-01

Family

ID=22670647

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108438-0A BR0108438A (pt) 2000-02-16 2001-02-16 Composição farmacêutica

Country Status (17)

Country Link
EP (1) EP1257248B1 (pt)
JP (1) JP2005503318A (pt)
KR (2) KR20030016227A (pt)
CN (1) CN1422142A (pt)
AT (1) ATE526917T1 (pt)
AU (2) AU4318901A (pt)
BR (1) BR0108438A (pt)
CA (1) CA2400178A1 (pt)
HU (1) HUP0204555A3 (pt)
MA (1) MA26883A1 (pt)
MX (1) MXPA02008072A (pt)
NO (1) NO20023866L (pt)
NZ (1) NZ520749A (pt)
PL (1) PL357111A1 (pt)
TW (1) TWI232756B (pt)
WO (1) WO2001060325A1 (pt)
ZA (1) ZA200206553B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
MXPA05002065A (es) 2002-09-05 2005-06-08 Galderma Sa Solucion para aplicacion ungueal.
KR101093990B1 (ko) * 2003-03-21 2011-12-16 넥스메드 홀딩스 인코포레이티드 항진균성 네일 코트 및 사용 방법
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
WO2007056068A2 (en) * 2005-11-02 2007-05-18 Bentley Pharmaceuticals, Inc. Macrocyclic formulations for transmembrane drug delivery
CA2633489C (en) * 2005-12-14 2013-09-24 Zars Pharma, Inc. Compositions and methods for treating dermatological conditions
US9579297B2 (en) 2005-12-28 2017-02-28 Teikoku Seiyaku Co., Ltd. Pharmaceutical composition for application to nail
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
BRPI1014529A2 (pt) * 2009-03-20 2015-08-25 Stiefel Laboratories Composições de monoglicerídeo de ácido graxo
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
WO2013078422A2 (en) 2011-11-23 2013-05-30 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
KR101580077B1 (ko) * 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
DE69216446T2 (de) * 1991-03-13 1997-06-26 Firmenich & Cie Verfahren zur Herstellung von 15-Pentadecanolid oder von an diesem Makrolid reichen Gemischen
EP0805673A1 (en) * 1994-10-20 1997-11-12 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
EP0983037B1 (en) * 1998-02-09 2003-05-02 MacroChem Corporation Antifungal nail lacquer
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
AU4318901A (en) 2001-08-27
PL357111A1 (en) 2004-07-12
HUP0204555A3 (en) 2004-06-28
KR20080049148A (ko) 2008-06-03
TWI232756B (en) 2005-05-21
ZA200206553B (en) 2003-11-17
KR20030016227A (ko) 2003-02-26
MA26883A1 (fr) 2004-12-20
EP1257248A1 (en) 2002-11-20
WO2001060325A1 (en) 2001-08-23
CN1422142A (zh) 2003-06-04
JP2005503318A (ja) 2005-02-03
CA2400178A1 (en) 2001-08-23
EP1257248A4 (en) 2007-10-03
HUP0204555A2 (en) 2003-05-28
NO20023866L (no) 2002-10-01
EP1257248B1 (en) 2011-10-05
NZ520749A (en) 2004-06-25
AU2001243189B2 (en) 2005-06-09
ATE526917T1 (de) 2011-10-15
MXPA02008072A (es) 2004-04-05
NO20023866D0 (no) 2002-08-15

Similar Documents

Publication Publication Date Title
BR0108438A (pt) Composição farmacêutica
BR9714739A (pt) Composição farmacêutica para reduzir a depressão respiratória e os efeitos colaterais inerentes de compostos opióides mu
BR9814729A (pt) Método e composição de uma preparação oral de itraconazol
BRPI0208147B8 (pt) processo para controlar a taxa de liberação de ingrediente agrícola ativo de semente tratada
KR870010865A (ko) 피복된 복용 형태
BR0315023A (pt) Distribuidor de composição anti-séptica de pele e método de preparar um distribuidor de composição anti-séptica de pele para uso
NO20062434L (no) Sammensetninger og fremgangsmater til a kontrollere legemiddeltap og -levering i transdermale legemiddelleveringssystemer
ATE184473T1 (de) Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
PT1150661E (pt) Produto para pulverizacao para aplicacao topica
BRPI0411982A (pt) glicano de aperfeiçoamento de terapia
BR0112841A (pt) Sistemas de revestimento de camadas múltiplas de uma camada de base semelhante a gel, de camada espessa, e uma camada de cobertura de laca de poliuretano, produção e uso dos mesmos
NZ544851A (en) A vanishing cream base composition suitable for topical administration of an active agent to an animal or plant
ES2192256T3 (es) Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.
BR0212028A (pt) Sistema terapêutico transdérmico (tts) com a substância ativa fentanila
BR9201854A (pt) Composto derivado de pridazinas,processo para sua preparacao,e,composicao farmaceutica
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
BR0112723A (pt) Tratamento aquoso de duas partes para proteção de metais
BR0317340A (pt) Formulações de hfc em solução contendo tiotrópio
BRPI0506496A (pt) conservantes antimicrobianos para obtenção de formulação de multidose usando beta-ciclodextrinas para formas de dosagem lìquidas
HUT57609A (en) Biologically decomposable antiseptics
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
HUP9903348A2 (hu) Transzdermális terápiás rendszer (tts) drogfüggőség vagy drogmegszokás kezelésére alkalmas hatóanyagok adagolására
BR0005646A (pt) Composição cosmética de alta permanência que compreende pelo menos um polìmero formador de filme dispositivo aerossol que compreende uma composição, processo cosmético e utilização de uma composição
BR9917219A (pt) Composições de revestimento para mascaramento de sabor
BR0112150A (pt) Veìculo para aplicação de compostos quìmicos em madeira

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: BENTLEY PHARMACEUTICALS, INC. (US)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDO NA PETICAO NO 020050027958/RJ DE 25/04/2005.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A, 10A E 11A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/4174 (2006.01), A61K 9/70 (2006.01), A61K